| Attribute |
Value |
| 52 Week Change |
-0.5774648 |
| Address1 |
664 Cruiser Lane |
| All Time High |
1,080.0 |
| All Time Low |
0.27 |
| Ask |
0.3089 |
| Ask Size |
300 |
| Average Daily Volume10 Day |
97,650 |
| Average Daily Volume3 Month |
1,686,271 |
| Average Volume |
1,686,271 |
| Average Volume10Days |
97,650 |
| Beta |
-0.2 |
| Bid |
0.3 |
| Bid Size |
4,300 |
| Book Value |
0.285 |
| City |
Belgrade |
| Compensation As Of Epoch Date |
1,767,139,200 |
| Country |
United States |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
0.3045 |
| Current Ratio |
2.162 |
| Custom Price Alert Confidence |
HIGH |
| Date Short Interest |
1,790,726,400 |
| Day High |
0.3045 |
| Day Low |
0.3 |
| Debt To Equity |
65.006 |
| Display Name |
Xtant Medical |
| Dividend Date |
1,518,566,400 |
| Dividend Yield |
0.0 |
| Earnings Call Timestamp End |
1,786,451,400 |
| Earnings Call Timestamp Start |
1,786,451,400 |
| Earnings Timestamp |
1,786,451,400 |
| Earnings Timestamp End |
1,794,313,800 |
| Earnings Timestamp Start |
1,794,313,800 |
| Ebitda |
-1,473,000 |
| Ebitda Margins |
-0.01345 |
| Enterprise To Ebitda |
-39.797 |
| Enterprise To Revenue |
0.535 |
| Enterprise Value |
58,621,196 |
| Eps Current Year |
-0.08 |
| Eps Forward |
-0.03 |
| Eps Trailing Twelve Months |
-0.08 |
| Esg Populated |
0 |
| Exchange |
ASE |
| Exchange Data Delayed By |
0 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fifty Day Average |
0.3472 |
| Fifty Day Average Change |
-0.042699993 |
| Fifty Day Average Change Percent |
-0.12298385 |
| Fifty Two Week Change Percent |
-57.746483 |
| Fifty Two Week High |
0.95 |
| Fifty Two Week High Change |
-0.64549994 |
| Fifty Two Week High Change Percent |
-0.67947364 |
| Fifty Two Week Low |
0.27 |
| Fifty Two Week Low Change |
0.034500003 |
| Fifty Two Week Low Change Percent |
0.12777779 |
| Fifty Two Week Range |
0.27 - 0.95 |
| Financial Currency |
USD |
| First Trade Date Milliseconds |
1,277,991,000,000 |
| Float Shares |
54,177,807 |
| Forward Eps |
-0.03 |
| Forward P E |
-10.150001 |
| Free Cashflow |
10,128,750 |
| Full Exchange Name |
NYSE American |
| Full Time Employees |
151 |
| Fullday Change |
0.0017000139 |
| Fullday Change Percent |
0.5614313 |
| Fullday Price |
0.3045 |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Gross Margins |
0.59389 |
| Gross Profits |
65,047,000 |
| Has Pre Post Market Data |
1 |
| Held Percent Insiders |
0.15648 |
| Held Percent Institutions |
0.56943 |
| Implied Shares Outstanding |
140,287,960 |
| Industry |
Medical Devices |
| Industry Disp |
Medical Devices |
| Industry Key |
medical-devices |
| Is Earnings Date Estimate |
1 |
| Language |
en-US |
| Last Fiscal Year End |
1,767,139,200 |
| Last Split Date |
1,518,566,400 |
| Last Split Factor |
1:12 |
| Long Business Summary |
Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. It offers OsteoSponge, a natural scaffold for cellular in-growth; OsteoSelect DBM Putty, a moldable demineralized bone matrix; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated and terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor Pro, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, an aseptically processed and viable bone allograft; and nanOss products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier. It also provides sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. In addition, it offers cervical products comprising Spider cervical plating, Streamline OCT system, and CervAlign systems; thoracolumbar products, such as of Axle-X interspinous fusion, Streamline MIS spinal fixation, Streamline TL spinal fixation, and HPS 2.0 hybrid performance systems; Silex sacroiliac joint fusion systems; interbody products comprising Calix for cervical and thoracolumbar applications, Irix-C Cervical and Irix-A lumbar integrated dusion systems, and Fortilink implants; Contact ALP (Anterior Lumbar Plate) System; and interlaminar stabilization products, such as Coflex device for lumbar spinal stenosis; and CoFix implants for back and disc pain. The company is headquartered in Belgrade, Montana. |
| Long Name |
Xtant Medical Holdings, Inc. |
| Market |
us_market |
| Market Cap |
42,717,688 |
| Market State |
REGULAR |
| Max Age |
86,400 |
| Message Board Id |
finmb_11129226 |
| Most Recent Quarter |
1,782,777,600 |
| Net Income To Common |
-11,137,000 |
| Next Fiscal Year End |
1,798,675,200 |
| Non Diluted Market Cap |
52,607,985 |
| Number Of Analyst Opinions |
3 |
| Open |
0.3 |
| Operating Cashflow |
570,000 |
| Operating Margins |
-0.18101999 |
| Payout Ratio |
0.0 |
| Peg Ratio |
1.74 |
| Phone |
406 388 0480 |
| Previous Close |
0.3028 |
| Price Eps Current Year |
-3.8062503 |
| Price Hint |
4 |
| Price To Book |
1.0684211 |
| Price To Sales Trailing12 Months |
0.3900197 |
| Profit Margins |
-0.10168 |
| Quick Ratio |
0.977 |
| Quote Source Name |
Nasdaq Real Time Price |
| Quote Type |
EQUITY |
| Recommendation Key |
none |
| Region |
US |
| Regular Market Change |
0.0017000139 |
| Regular Market Change Percent |
0.5614313 |
| Regular Market Day High |
0.3045 |
| Regular Market Day Low |
0.3 |
| Regular Market Day Range |
0.3 - 0.3045 |
| Regular Market Open |
0.3 |
| Regular Market Previous Close |
0.3028 |
| Regular Market Price |
0.3045 |
| Regular Market Time |
1,792,159,767 |
| Regular Market Volume |
4,257 |
| Return On Assets |
-0.0375 |
| Return On Equity |
-0.25164 |
| Revenue Growth |
-0.35 |
| Revenue Per Share |
0.782 |
| Sand P52 Week Change |
0.16207206 |
| Sector |
Healthcare |
| Sector Disp |
Healthcare |
| Sector Key |
healthcare |
| Shares Outstanding |
140,287,960 |
| Shares Percent Shares Out |
0.001 |
| Shares Short |
143,564 |
| Shares Short Previous Month Date |
1,788,134,400 |
| Shares Short Prior Month |
1,828,008 |
| Short Name |
Xtant Medical Holdings, Inc. |
| Short Percent Of Float |
0.0026 |
| Short Ratio |
0.17 |
| Source Interval |
15 |
| State |
MT |
| Symbol |
XTNT |
| Target High Price |
1.5 |
| Target Low Price |
0.6 |
| Target Mean Price |
1.03333 |
| Target Median Price |
1.0 |
| Total Cash |
9,870,000 |
| Total Cash Per Share |
0.07 |
| Total Debt |
26,012,000 |
| Total Revenue |
109,527,000 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
0.0 |
| Trailing Annual Dividend Yield |
0.0 |
| Trailing Eps |
-0.08 |
| Trailing Peg Ratio |
None |
| Triggerable |
1 |
| Two Hundred Day Average |
0.4849 |
| Two Hundred Day Average Change |
-0.18039998 |
| Two Hundred Day Average Change Percent |
-0.37203544 |
| Type Disp |
Equity |
| Volume |
4,257 |
| Website |
https://xtantmedical.com |
| Zip |
59,714 |